Watchlist Price Alert

Theriva Biologics Inc. (TOVX)

AMEX: TOVX · Real-Time Price · USD

0.61

0.09 (17.87%)

At close: May 13, 2025, 12:16 PM

Theriva Biologics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	135K	268K	87K	201K	240K	272K	245K	157K
Gross Profit	n/a	-135K	-268K	-87K	-201K	-240K	-272K	-245K	-157K
Operating Income	-26.35M	-21.43M	-21.58M	-14.27M	-10.16M	-15.66M	-17.57M	-26.25M	-39.25M
Interest Income	697K	1.44M	512K	6K	44K	283K	67K	21K	37K
Pretax Income	-25.65M	-19.99M	-21.11M	-14.27M	-10.12M	-15.38M	-13.42M	-15.49M	-27.8M
Net Income	-25.65M	-18.35M	-19.68M	-14.17M	-10M	-15.02M	-13.37M	-15.17M	-27.25M
Selling & General & Admin	7.4M	7.78M	9.86M	6.47M	5.03M	4.58M	5.73M	7.47M	10.14M
Research & Development	12.03M	14.31M	11.72M	7.8M	5.13M	11.08M	11.84M	18.78M	29.11M
Other Expenses	n/a	-660K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	19.43M	21.43M	21.58M	14.27M	10.16M	15.66M	17.57M	26.25M	39.25M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	624K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	26.35M	21.43M	21.58M	14.27M	10.16M	15.66M	17.57M	26.25M	39.25M
Income Tax Expense	n/a	-1.64M	-1.43M	-94K	-117K	-360K	-4.2M	-11.08M	-12M
Shares Outstanding (Basic)	1.35M	644K	613.09K	12.19M	1.9M	1.64M	623.24K	355.33K	269.4K
Shares Outstanding (Diluted)	1.35M	644.28K	613.09K	12.19M	1.9M	1.64M	623.24K	355.33K	269.4K
EPS (Basic)	-19.03	-28.49	-32.11	-1.16	-5.26	-9.14	-21.45	-42.7	-101.17
EPS (Diluted)	-19.03	-28.48	-32.11	-1.16	-5.26	-9.14	-21.45	-42.7	-101.17
EBITDA	-25.52M	-19.85M	-21.58M	-14.19M	-9.96M	-15.42M	-17.3M	-26.01M	-39.09M
EBIT	n/a	-19.99M	-21.11M	-14.27M	-10.16M	-15.66M	-17.57M	-26.25M	-39.25M
Depreciation & Amortization	n/a	135K	268K	87K	201K	240K	272K	245K	157K